Precision Medicine and Decision Making in Breast Cancer

By Elizabeth Gardner

Chicago—Although there is continued debate about how much precision approaches can influence cancer care—with early reports from the NCI Match trial showing limited application of genomic results despite a focused initiative (Table)—breast cancer can provide a template for how precision medicine can be applied to improve patient management, according to Steven Katz, MD, the director of the sociobehavioral research program at the University of Michigan